Mesoblast

Company MSB

Last mentioned: 3h ago

Timeline

  1. Reporting Season Pressure

    Difficult February reports for CSL and Sonic Healthcare extend index declines.

  2. Anteris Funding

    Anteris Technologies raises approximately $440 million for heart valve technology.

  3. Nasdaq Biotech Peak

    The index records a 30% annual gain, diverging from broader tech markets.

  4. Record Funding Year

    Clarity ($200m) and Mesoblast ($260m) complete significant capital raises.

  5. ASX Healthcare Slump

    The sector begins a calendar year decline of 25% led by major heavyweights.

Stories mentioning Mesoblast 1